BIOMAT Database Logo BIOMAT Database Logo

Ciprofloxacin for gonorrhea--250 mg or 500 mg? 1996

J S Moran

UI MeSH Term Description Entries
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D006069 Gonorrhea Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879. Neisseria gonorrhoeae Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.

Related Publications

J S Moran
Pharmacokinetic/pharmacodynamic modelling of ciprofloxacin 250 mg/12 h versus 500 mg/24 h for urinary infections.
July 2002, The Journal of antimicrobial chemotherapy,
J S Moran
Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin.
January 1991, Chemotherapy,
J S Moran
Efficacy of 250 mg trospectomycin sulfate i.m. vs. 250 mg ceftriaxone i.m. for treatment of uncomplicated gonorrhea.
January 1994, Sexually transmitted diseases,
J S Moran
Ciprofloxacin 250 mg for treating gonococcal urethritis and cervicitis.
December 2000, Sexually transmitted infections,
J S Moran
Treating uncomplicated gonococcal infection with 250 mg or 100 mg ciprofloxacin in a single oral dose.
April 1988, Genitourinary medicine,
J S Moran
Pharmacodynamics of 250 mg and 500 mg oral furosemide in peritoneal dialysis
.
December 2019, International journal of clinical pharmacology and therapeutics,
J S Moran
Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension.
March 1999, The Journal of antimicrobial chemotherapy,
J S Moran
Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial.
January 2014, Journal of the National Cancer Institute,
J S Moran
Cephalexin concentrations in radicular granuloma following a single oral administration of 250- or 500-mg cephalexin.
December 1994, General pharmacology,
J S Moran
Study on the bioequivalence of ciprofloxacin 500 mg orally versus 200 mg i.v.
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
Copied contents to your clipboard!